The SELECT trial measured outcomes over years, not weeks
Most patients on GLP-1 medications should aim for 1.01.5 grams of protein per kilogram of ideal body weight daily, which translates to approximately 0.450.68 grams per pound of goal weight
[DOI] [PMC free article] [PubMed] [Google Scholar] 28
For eligible trials identified through our database searches, we utilised ClinicalTrials.gov, using their respective National Clinical Trial (NCT) identifiers, to retrieve additional information when outcome data were absent or incomplete in the published articles
Based on this data, contemporary guidelines now support GLP-1RA use, notably semaglutide, as the fourth pillar of diabetic kidney disease (DKD) management in T2D, alongside existing cardio-kidney protective agents (the other 3 pillars of DKD therapy) sodium glucose co-transporter-2 inhibitors, non-steroidal mineralocorticoid receptor antagonists and renin-angiotensin-aldosterone-system blockers
Knowing your concentration is essential for calculating accurate doses using a semaglutide syringe dosage chart